This commentary refers to ‘Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies’, by P.R. Lawler et al., 2020;41:86–94.

中文翻译：

---

降低甘油三酸酯的药物：不仅是二十碳五乙酯

这篇评论提到PR Lawler等人，2020； 41：86-94，“在患有动脉粥样硬化性心血管疾病并可能符合新兴疗法的个体中，与高甘油三酯血症相关的心血管结果的现实世界风险” 。